Literature DB >> 18777168

Biological and behavioural explanations of social inequalities in coronary heart disease: the Whitehall II study.

M G Marmot1, M J Shipley, H Hemingway, J Head, E J Brunner.   

Abstract

AIMS/HYPOTHESIS: We determined the degree to which metabolic syndrome components, inflammation and health behaviours account for the social gradient in CHD.
METHODS: A total of 5312 men, initially aged 39 to 63 years, were followed for 13.1 years for incident coronary death or non-fatal myocardial infarction according to socioeconomic position (employment grade). The contribution of explanatory factors to socioeconomic differences in CHD was assessed by the reduction in hazard ratios computed using Cox models. The effects of measurement error were taken into account.
RESULTS: Coronary events were more common in lower employment grades than in higher, with a hazard ratio (relative index of inequality) of 2.2 (95% CI 1.3-3.7), after adjustment for age and ethnic group. Behavioural risk factors (mainly smoking and diet) explained a third of the socioeconomic gradient in CHD incidence. Components of the metabolic syndrome and inflammatory markers predicted CHD incidence and also explained a third of the gradient. Combined, these two groups of predictors, i.e. behavioural and biological, accounted for over half of the socioeconomic gradient in incident CHD. Adding body height as a marker of the effects of early life increased this figure to about 60%. CONCLUSIONS/
INTERPRETATION: A major question has been how someone's socioeconomic position can lead to increased risk of CHD. Socioeconomic differences in components of the metabolic syndrome (and inflammatory markers) provide part of the answer. This was, to an important degree, independent of the contribution of health behaviours to the socioeconomic differentials in CHD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18777168      PMCID: PMC2788759          DOI: 10.1007/s00125-008-1144-3

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  44 in total

1.  Relative index of inequality: definition, estimation, and inference.

Authors:  Jamie C Sergeant; David Firth
Journal:  Biostatistics       Date:  2005-09-28       Impact factor: 5.899

2.  Association between plasma IL-6, the IL6 -174G>C gene variant and the metabolic syndrome in type 2 diabetes mellitus.

Authors:  Jeffrey W Stephens; Steven J Hurel; Gordon D O Lowe; Ann Rumley; Steve E Humphries
Journal:  Mol Genet Metab       Date:  2006-11-22       Impact factor: 4.797

3.  Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study.

Authors:  Johan Sundström; Ulf Risérus; Liisa Byberg; Björn Zethelius; Hans Lithell; Lars Lind
Journal:  BMJ       Date:  2006-03-01

4.  Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study.

Authors:  Julia Hippisley-Cox; Carol Coupland; Yana Vinogradova; John Robson; Margaret May; Peter Brindle
Journal:  BMJ       Date:  2007-07-05

5.  Does autonomic function link social position to coronary risk? The Whitehall II study.

Authors:  Harry Hemingway; Martin Shipley; Eric Brunner; Annie Britton; Marek Malik; Michael Marmot
Journal:  Circulation       Date:  2005-06-06       Impact factor: 29.690

6.  Cohort Profile: the Whitehall II study.

Authors:  Michael Marmot; Eric Brunner
Journal:  Int J Epidemiol       Date:  2004-12-02       Impact factor: 7.196

7.  Prospective effect of job strain on general and central obesity in the Whitehall II Study.

Authors:  Eric J Brunner; Tarani Chandola; Michael G Marmot
Journal:  Am J Epidemiol       Date:  2007-01-22       Impact factor: 4.897

8.  Chronic stress at work and the metabolic syndrome: prospective study.

Authors:  Tarani Chandola; Eric Brunner; Michael Marmot
Journal:  BMJ       Date:  2006-01-20

9.  Insight into the nature of the CRP-coronary event association using Mendelian randomization.

Authors:  Juan P Casas; Tina Shah; Jackie Cooper; Emma Hawe; Alex D McMahon; Dairena Gaffney; Christopher J Packard; Denis S O'Reilly; Irene Juhan-Vague; John S Yudkin; Elena Tremoli; Maurizio Margaglione; Giovanni Di Minno; Anders Hamsten; Teake Kooistra; Jeffrey W Stephens; Steven J Hurel; Shona Livingstone; Helen M Colhoun; George J Miller; Leonelo E Bautista; Tom Meade; Naveed Sattar; Steve E Humphries; Aroon D Hingorani
Journal:  Int J Epidemiol       Date:  2006-03-24       Impact factor: 7.196

10.  A multi-state model for joint modelling of terminal and non-terminal events with application to Whitehall II.

Authors:  F Siannis; V T Farewell; J Head
Journal:  Stat Med       Date:  2007-01-30       Impact factor: 2.373

View more
  37 in total

Review 1.  Aging with a disability: a systematic review of cardiovascular disease and osteoporosis among women aging with a physical disability.

Authors:  Andrea L Rosso; Jennifer Pelt Wisdom; Willi Horner-Johnson; Marjorie G McGee; Yvonne L Michael
Journal:  Maturitas       Date:  2010-11-13       Impact factor: 4.342

2.  Considering the Role of Stress in Populations of High-Risk, Underserved Community Networks Program Centers.

Authors:  James R Hébert; Kathryn L Braun; Joseph Keawe'aimoku Kaholokula; Cheryl A Armstead; James B Burch; Beti Thompson
Journal:  Prog Community Health Partnersh       Date:  2015

3.  Unequal Exposure or Unequal Vulnerability? Contributions of Neighborhood Conditions and Cardiovascular Risk Factors to Socioeconomic Inequality in Incident Cardiovascular Disease in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Mustafa Hussein; Ana V Diez Roux; Mahasin S Mujahid; Theresa A Hastert; Kiarri N Kershaw; Alain G Bertoni; Ana Baylin
Journal:  Am J Epidemiol       Date:  2018-07-01       Impact factor: 4.897

4.  Accumulating knowledge on the social determinants of health and infectious disease.

Authors:  Paula Braveman
Journal:  Public Health Rep       Date:  2011 Sep-Oct       Impact factor: 2.792

5.  Risk of ischemic heart disease following occupational exposure to welding fumes: a systematic review with meta-analysis.

Authors:  Emina Mocevic; Pernille Kristiansen; Jens Peter Bonde
Journal:  Int Arch Occup Environ Health       Date:  2014-07-22       Impact factor: 3.015

6.  Modeling the association between lifecourse socioeconomic disadvantage and systemic inflammation in healthy adults: The role of self-control.

Authors:  Camelia E Hostinar; Kharah M Ross; Edith Chen; Gregory E Miller
Journal:  Health Psychol       Date:  2014-08-11       Impact factor: 4.267

Review 7.  [Socioeconomic status and inflammatory biomarkers of cardiovascular diseases: How do education, occupation and income operate?].

Authors:  F Rosenbach; M Richter; T-K Pförtner
Journal:  Herz       Date:  2014-01-23       Impact factor: 1.443

8.  Socioeconomic status and subclinical coronary disease in the Whitehall II epidemiological study.

Authors:  Andrew Steptoe; Mark Hamer; Katie O'Donnell; Shreenidhi Venuraju; Michael G Marmot; Avijit Lahiri
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

9.  Current European guidelines for management of arterial hypertension: are they adequate for use in primary care? Modelling study based on the Norwegian HUNT 2 population.

Authors:  Halfdan Petursson; Linn Getz; Johann A Sigurdsson; Irene Hetlevik
Journal:  BMC Fam Pract       Date:  2009-10-30       Impact factor: 2.497

10.  Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database.

Authors:  T Sokka; H Kautiainen; T Pincus; S Toloza; G da Rocha Castelar Pinheiro; J Lazovskis; M L Hetland; T Peets; K Immonen; J F Maillefert; A A Drosos; R Alten; C Pohl; B Rojkovich; B Bresnihan; P Minnock; M Cazzato; S Bombardieri; S Rexhepi; M Rexhepi; D Andersone; S Stropuviene; M Huisman; S Sierakowski; D Karateev; V Skakic; A Naranjo; E Baecklund; D Henrohn; F Gogus; H Badsha; A Mofti; P Taylor; C McClinton; Y Yazici
Journal:  Ann Rheum Dis       Date:  2009-07-30       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.